What is Bevacizumab?
Bevacizumab is a general prescription drug that is used intravenously. Doctors usually prescribe this for the treatment of certain types of cancer, as well as a rare condition that affects the eyes known as angiomatous proliferation of the retina. The drug generally attacks cancer cells by not allowing them to grow new blood vessels, reducing their food supply. Cancer occurs when cells in a certain part of the body begin to grow uncontrollably and create masses called tumors. Cancer cells of nutrients require continuing to continue growth. Like all cells, cancer receives its desired oxygen and blood minerals supplied by small tubes called blood vessels. Once Bevacizumab binds to vascular endothelial growth factor A, cancer cells become unable to produce the blood vessels. Since the drug works in this way, the name inhibitor of angiogenesis - angio means blood vessels, while Genesis means origin. In this way bevacizumab slows the rate of growth RAKOwine cells. This helps to prevent the spread of the disease to other parts of the body. In some cases, cancer cells eventually die due to the effects of the drug.
Bevacizumab is a monoclonal antibody-bio engineering chemical that works similarly to immune cells by influencing only one particular type of cell in the body. In this case, cells focus only on those containing growth factor A. On the other hand, chemotherapy medicines do not have the ability to distinguish one type of cell from another. Instead, they also perform their actions for healthy cells of cancer cells.
Not all cancer types respond to bevacizumab. Doctors usually prescribe a drug for the treatment of colon cancer or rectum that has metastasized or spread to other parts of the body. It is also effective as treatment of lung cancer called Ne-Squamous, Nemasolabřík and also the type of brain tumor known as glioblastoma. Although less common,Treatment also works against some forms of kidney and breast cancer.
patients can also receive Bevacizumab for the treatment of angiomatous proliferation of the retina. The retina proliferation occurs when blood vessels grow on the surface of the retina - part of the eye, which is primarily responsible for vision. The condition results in a gradual loss of vision, which can slow down or prevent the drug by preventing the growth of blood vessels.
Scientists continue to study the effects of bevacizumab on other types of cancer and health conditions. Other types of monoclonal antibodies of Medicationty also evolve in the hope of providing new ways of treatment of diseases. Although this is not a medicine, these medicines usually need a qualified doctor.